Monopar begins rolling NDA submission for Wilson disease drug
Go back to Monopar begins rolling NDA submission for Wilson disease drug| (NASDAQ: MNPR) | Delayed: 102.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.70 | 52 Week High | $ | |||
| Open | $103.33 | 52 Week Low | $ | |||
| Day High | $104.09 | P/E | N/A | |||
| Day Low | $98.90 | EPS | $ | |||
| Volume | 22 | |||||
